These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 606144)

  • 1. Application of various chemotherapeutic agents in experimental bovine anaplasmosis.
    Sharma SK; Banerjee DP; Gautam OP
    Ann Rech Vet; 1977; 8(3):307-13. PubMed ID: 606144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of oxytetracycline and a dithiosemicarbazone in the treatment of bovine anaplasmosis.
    Kuttler KL
    Am J Vet Res; 1971 Sep; 32(9):1349-52. PubMed ID: 5094519
    [No Abstract]   [Full Text] [Related]  

  • 3. Combined treatment with a dithiosemicarbazone and oxytetracycline to eliminate Anaplasma marginale infections in splenectomized calves.
    Kuttler KL
    Res Vet Sci; 1972 Nov; 13(6):536-9. PubMed ID: 4648995
    [No Abstract]   [Full Text] [Related]  

  • 4. Efficacy of a new oxytetracycline formulation against clinical anaplasmosis.
    Magonigle RA; Simpson JE; Frank FW
    Am J Vet Res; 1978 Sep; 39(9):1407-10. PubMed ID: 697150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotherapy of experimental bovine petechial fever.
    Snodgrass DR
    Res Vet Sci; 1976 Jan; 20(1):108-9. PubMed ID: 130668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of gloxazone, an effective but toxic anaplasmacide, with imidocarb dihydrochloride.
    McHardy N; Berger J; Taylor RJ; Farebrother D; James JA
    Res Vet Sci; 1980 Sep; 29(2):198-202. PubMed ID: 6451008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunity to bovine anaplasmosis after elimination of the carrier status with oxytetracycline hydrochloride.
    Renshaw HW; Magonigle RA; Eckblad WP; Frank FW
    Proc Annu Meet U S Anim Health Assoc; 1976; (80):79-88. PubMed ID: 1078098
    [No Abstract]   [Full Text] [Related]  

  • 8. Bovine anaplasmosis: elimination of the carrier state with injectable long-acting oxytetracycline.
    Swift BL; Thomas GM
    J Am Vet Med Assoc; 1983 Jul; 183(1):63-5. PubMed ID: 6874524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elimination of the carrier state of bovine anaplasmosis with a long-acting oxytetracycline.
    Roby TO; Simpson JE; Amerault TE
    Am J Vet Res; 1978 Jul; 39(7):1115-6. PubMed ID: 677530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elimination of the carrier state of bovine anaplasmosis with imidocarb.
    Roby TO; Mazzola V
    Am J Vet Res; 1972 Oct; 33(10):1931-3. PubMed ID: 5074698
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparative efficacy of drugs in bovine anaplasmosis.
    Mishra AK; Sharma NN
    Trop Anim Health Prod; 1979 Nov; 11(4):222-6. PubMed ID: 552672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the efficacy of enrofloxacin, imidocarb, and oxytetracycline for clearance of persistent Anaplasma marginale infections in cattle.
    Coetzee JF; Apley MD; Kocan KM
    Vet Ther; 2006; 7(4):347-60. PubMed ID: 17216590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of five daily intravenous treatments with oxytetracycline hydrochloride on the carrier status of bovine anaplasmosis.
    Magonigle RA; Renshaw HW; Vaughn HW; Stauber EH; Frank FW
    J Am Vet Med Assoc; 1975 Dec; 167(12):1080-3. PubMed ID: 1194114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacotherapeutics of drugs used in treatment of anaplasmosis and babesiosis.
    Kuttler KL
    J Am Vet Med Assoc; 1980 May; 176(10 Spec No):1103-8. PubMed ID: 7216881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of a second Anaplasma exposure on the success of treatment to eliminate Anaplasma carrier infections in cattle.
    Kuttler KL
    Am J Vet Res; 1983 May; 44(5):882-3. PubMed ID: 6869997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of an experimental long-acting oxytetracycline (Terramycin/LA) in the treatment of acute anaplasmosis.
    Kuttler KL; Young MF; Simpson JE
    Vet Med Small Anim Clin; 1978 Feb; 73(2):187-92. PubMed ID: 245908
    [No Abstract]   [Full Text] [Related]  

  • 17. Bovine anaplasmosis: clinical, hematologic, and serologic manifestations in cows given a long-acting oxytetracycline formulation in the prepatent period.
    Lincoln SD; Eckblad WP; Magonigle RA
    Am J Vet Res; 1982 Aug; 43(8):1360-2. PubMed ID: 7103219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response of cattle upon reexposure to Anaplasma marginale after elimination of chronic carrier infections.
    Magonigle RA; Newby TJ
    Am J Vet Res; 1984 Apr; 45(4):695-7. PubMed ID: 6731981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultrastructural and fluorochromatic changes of Anaplasma marginale exposed to oxytetracycline, imidocarb and enrofloxacin in short-term erythrocyte cultures.
    Coetzee JF; Kocan KM; Higgins JJ; Apley MD; Jones DE
    Vet Microbiol; 2009 Apr; 136(1-2):45-53. PubMed ID: 19054634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anaplasmosis: prevalence, treatment, and cattle to elk transmission studies.
    Renshaw HW; Magonigle RA; Stauber EH; Vaughn HW; Frank FW
    Proc Annu Meet U S Anim Health Assoc; 1975; (79):70-84. PubMed ID: 1078068
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.